1. Global tuberculosis report 2015. 20th edition [Internet]. Geneva: World Health Organization;c2015. [cited 2016 Nov 23]. Available from. http://apps.who.int/iris/bitstream/10665/191102/1/9789241565059_eng.pdf.
2. Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, et al. Xpert® MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2013; (1):CD009593.
Article
3. Dodd PJ, Gardiner E, Coghlan R, Seddon JA. Burden of childhood tuberculosis in 22 high-burden countries: a mathematical modelling study. Lancet Glob Health. 2014; 2:e453–9.
Article
4. Jenkins HE, Tolman AW, Yuen CM, Parr JB, Keshavjee S, Pérez-Vélez CM, et al. Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates. Lancet. 2014; 383:1572–9.
Article
5. Siddiqi K, Lambert ML, Walley J. Clinical diagnosis of smear-negative pulmonary tuberculosis in low-income countries: the current evidence. Lancet Infect Dis. 2003; 3:288–96.
Article
6. Shin JA, Chang YS, Kim TH, Kim HJ, Ahn CM, Byun MK. Fiberoptic bronchoscopy for the rapid diagnosis of smear-negative pulmonary tuberculosis. BMC Infect Dis. 2012; 12:141.
Article
7. Yoo R, Kim JI, Kim S, Lee J. Discordance between tuberculin skin test and interferon-gamma release assays for diagnosis of tuberculosis infection in Korean children. Pediatr Infect Vaccine. 2016; 23:18–24.
Article
8. Jo YS, Park JH, Lee JK, Heo EY, Chung HS, Kim DK. Discordance between MTB/RIF and realtime tuberculosis-specific polymerase chain reaction assay in bronchial washing specimen and its clinical implications. PLoS One. 2016; 11:e0164923.
Article
9. Tamura A, Shimada M, Matsui Y, Kawashima M, Suzuki J, Ariga H, et al. The value of fiberoptic bronchoscopy in culture-positive pulmonary tuberculosis patients whose pre-bronchoscopic sputum specimens were negative both for smear and PCR analyses. Intern Med. 2010; 49:95–102.
Article
10. Lee SJ, Yoon DK, Kim SH, Park IW, Choi BW, Hue SH, et al. Diagnosis of suspected active pulmonary tuberculosis by flexible fiberoptic bronchoscopy. Tuberc Respir Dis. 1989; 36:22–7.
Article
11. Le Palud P, Cattoir V, Malbruny B, Magnier R, Campbell K, Oulkhouir Y, et al. Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis. BMC Pulm Med. 2014; 14:137.
Article
12. Schoch OD, Rieder P, Tueller C, Altpeter E, Zellweger JP, Rieder HL, et al. Diagnostic yield of sputum, induced sputum, and bronchoscopy after radiologic tuberculosis screening. Am J Respir Crit Care Med. 2007; 175:80–6.
Article
13. Dasgupta K, Menzies D. Cost-effectiveness of tuberculosis control strategies among immigrants and refugees. Eur Respir J. 2005; 25:1107–16.
Article
14. Kang SJ, Kim YH, Jung CY, Lee HJ, Hyun MC. Clinical characteristics and radiologic patterns of adelescents with pulmonary tuberculosis: relevance to the reactive tuberculosis. Pediatr Allergy Respir Dis. 2012; 22:163–70.
Article
15. Rapid diagnostic tests for tuberculosis: what is the appropriate use? American Thoracic Society Workshop. Am J Respir Crit Care Med. 1997; 155:1804–14.
16. Iyer VN, Joshi AY, Boyce TG, Brutinel MW, Scalcini MC, Wilson JW, et al. Bronchoscopy in suspected pulmonary TB with negative induced-sputum smear and MTD(®) Gen-probe testing. Respir Med. 2011; 105:1084–90.
17. Bai GH, Park YK, Choi YW, Bai JI, Kim HJ, Chang CL, et al. Trend of anti-tuberculosis drug resistance in Korea, 1994-2004. Int J Tuberc Lung Dis. 2007; 11:571–6.
18. Kahn MA, Whitcomb ME, Snider GL. Flexible fiberoptic bronchoscopy. Am J Med. 1976; 61:151–5.